Breaking News, Collaborations & Alliances

Adare Partners with Veeva to Strengthen Quality Operations

Vault Quality Suite to connect quality processes, documents, and training on a single platform for improved efficiency and collaboration.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Veeva Systems announced that Adare Pharma Solutions, a contract development and manufacturing organization (CDMO) with expertise in oral dosage forms, selected Veeva Vault Quality Suite to harmonize quality systems across the organization. By replacing legacy systems with modern connected applications, Adare can streamline quality processes, work more effectively with partners and suppliers, and deliver greater visibility into operations to customers.

“As Adare expands its business, standardizing on the technology many of our customers use is a top priority to streamline collaboration,” said Audrey Butler, vice president, global head of quality at Adare Pharma Solutions. “Veeva Vault Quality Suite will bring together our global teams on one platform for seamless processes and real-time data access that can help us improve how we work with clients and deliver differentiated services.”

Adare will use Vault Quality Suite to simplify its quality operations across its sites in the United States, France, and Italy. The company will use Veeva Vault QMS to manage all quality processes, Veeva Vault QualityDocs to control documents and ensure quality, and Veeva Vault Training to drive employee qualifications. Adare can now manage content, data, and training in a single end-to-end quality system.

Ashley Wentworth, senior director, Veeva Vault Quality strategy, said, “We’re proud to partner with Adare Pharma Solutions to help support their goals of improving services for clients and delivering transformational medicines for patients. With the Veeva Vault Quality Suite, Adare will have a scalable cloud platform that can keep up with evolving industry and customer requirements.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters